CORC

在结果中检索

CORC

浏览/检索结果: 共15条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Trends of Postoperative Radiotherapy for Completely Resected Non-small Cell Lung Cancer in China: A Hospital-Based Multicenter 10-Year (2005-2014) Retrospective Clinical Epidemiological Study 期刊论文
FRONTIERS IN ONCOLOGY, 2019, 卷号: 9
作者:  Men, Yu;  Wang, Le;  Zhang, Ye;  Gao, Shugeng;  Li, Junling
收藏  |  浏览/下载：27/0  |  提交时间：2019/12/04
The respiratory tract microbiome and its relationship to lung cancer and environmental exposures found in rural china. 期刊论文
Environmental and molecular mutagenesis, 2019, 卷号: 60, 期号: 7
作者:  Hosgood H Dean;  Mongodin Emmanuel F;  Wan Yunhu;  Hua Xing;  Rothman Nathaniel
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/04
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:  Wu, Yi-Long;  Xu, Chong-Rui;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/04
Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6) 期刊论文
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2018, 卷号: 11, 期号: 1
作者:  Wu, Yi-Long;  Hirsh, Vera;  Sequist, Lecia V.;  Hu, Cheng-Ping;  Feng, Jifeng
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/04
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) 期刊论文
CLINICAL LUNG CANCER, 2016, 卷号: 17, 期号: 2
作者:  Zhou, Caicun;  Huang, Yunchao;  Wang, Donglin;  An, Changshan;  Zhou, Fuxiang
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/04
Symptom and Quality of Life Improvement in LUX-Lung 6 An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2015, 卷号: 10, 期号: 6
作者:  Geater, Sarayut L.;  Xu, Chong-Rui;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/04
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials 期刊论文
LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 2
作者:  Yang, James Chih-Hsin;  Wu, Yi-Long;  Schuler, Martin;  Sebastian, Martin;  Popat, Sanjay
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/04
Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial 期刊论文
LANCET ONCOLOGY, 2014, 卷号: 15, 期号: 2
作者:  Wu, Yi-Long;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng;  Lu, Shun
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/04
Demonstration program of population-based lung cancer screening in China: Rationale and study design 期刊论文
THORACIC CANCER, 2014, 卷号: 5, 期号: 3
作者:  Zhou, Qinghua;  Fan, Yaguang;  Wu, Ning;  Huang, Yunchao;  Wang, Ying
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/04
Multicenter randomized double-blind controlled phase III study of hhpg-19K as prophylactic therapy in patients with advanced non-small cell lung cancer (NSCLC) receiving myelosuppressive chemotherapy 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2014, 卷号: 32, 期号: 15
作者:  Zhou, Caicun;  Huang, Yunchao;  An, Changshan;  Wang, Donglin;  He, Jianxing
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/04

©版权所有 ©2017 CSpace - Powered by CSpace